Maravai Lifesciences Holdings (MRVI) Total Non-Current Liabilities (2020 - 2026)

Maravai Lifesciences Holdings' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $308.1 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 20.09% year-over-year to $308.1 million; the TTM figure through Mar 2026 stood at $308.1 million (down 20.09% YoY), while the FY2025 annual figure was $361.4 million, down 4.54% from the prior year.
• Total Non-Current Liabilities was $308.1 million for Q1 2026 at Maravai Lifesciences Holdings, down from $361.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q4 2022 to a low of $308.1 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $825.2 million across 5 years, with a median of $617.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities gained 16.03% in 2022, then tumbled 54.87% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $1.4 billion in 2022, then plunged by 53.33% to $638.1 million in 2023, then slumped by 40.67% to $378.6 million in 2024, then retreated by 4.54% to $361.4 million in 2025, then decreased by 14.76% to $308.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $308.1 million (Q1 2026), $361.4 million (Q4 2025), and $379.4 million (Q3 2025), per Business Quant data.